Article Text

PDF

Controlled trial of cimetidine in upper gastrointestinal haemorrhage.
  1. S J La Brooy,
  2. J J Misiewicz,
  3. J Edwards,
  4. P M Smith,
  5. S J Haggie,
  6. L Libman,
  7. M Sarner,
  8. J H Wyllie,
  9. J Croker,
  10. P Cotton

    Abstract

    One hundred and one patients were studied in a double-blind controlled trial to assess the role of oral cimetidine in preventing the continuation or recurrence of acute upper gastrointestinal haemorrhage from various sources, chiefly peptic ulcer. The dose of cimetidine was 800 mg on entering the study followed by 400 mg six hourly. The source of bleeding was identified endoscopically in 96% of patients, peptic ulcer comprising 70%. Bleeding continued or recurred in 11 of 51 (21.5%) of patients on cimetidine and in 12 of 50 (24%) of patients on placebo. Analysis of the effect of cimetidine according to age or severity of bleeding showed no significant advantage for the drug.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.